Sanofi ADR
NASDAQ: SNY
$47.82
-$1.69 (-3.4%)
Closing Price on November 14, 2024
SNY Articles
The top analyst upgrades, downgrades and initiations seen on Thursday included American Eagle Outfitters, Facebook, Nutrisystem, Pfizer, Roku, SeaWorld, Valero Energy and Zynga.
Published:
Last Updated:
2018 has been a strange time for investors. While the U.S. stock market sits close to all-time highs, many of the emerging and other developed markets nations have seen their shares take a beating....
Published:
Last Updated:
The more recent observations about Buffett's portfolio changes coming into mid-2018 have been quite different than many of the historic and traditional Buffett picks.
Published:
Last Updated:
The include top analyst upgrades, downgrades and other research calls from Wednesday Akamai Technologies, Apple, AutoZone, Dropbox, Electronic Arts, Ford, Kinder Morgan, Pandora Media, Procter &...
Published:
Last Updated:
Regeneron Pharmaceuticals and Sanofi are committing to lowering the price of the anti-cholesterol drug Praluent.
Published:
Last Updated:
The top analyst upgrades, downgrades and other research calls from Friday include Albermarle, Allergan, Boston Scientific, eBay, FedEx, Gogo, LendingTree, Nokia, UPS and Vertex Pharmaceuticals.
Published:
Last Updated:
24/7 Wall St. has tracked many of the so-called whale watching trades made by America's top investment managers, hedge fund managers and independent investors.
Published:
Last Updated:
Bioverativ is adding to Monday’s M&A news after it was announced that Sanofi would be acquiring the firm.
Published:
Last Updated:
Alnylam Pharmaceuticals saw its shares make a handy gain on Wednesday after the firm gave an update on its late-stage trial in patients with hereditary ATTR amyloidosis with polyneuropathy.
Published:
Last Updated:
Here are 10 of the most notable top picks from Credit Suisse in European equities for U.S. investors.
Published:
Last Updated:
According to Merrill Lynch, the health care sector should act as a good hedge against volatility. Even biotech was shown to offer growth at a reasonable price.
Published:
Last Updated:
The top analyst upgrades, downgrades and other research calls from Friday include Ambarella, Apple, Campbell Soup, Gap, Kinross Gold, Lululemon Athletica and Palo Alto Networks.
Published:
Last Updated:
The top analyst upgrades, downgrades and other research calls from Wednesday include Blackstone, Ciena, Merck, Tempur Sealy and Universal Display.
Published:
Last Updated:
24/7 Wall St. takes a look at the ASCO annual meeting each year and picks out the companies that could have the biggest boom or bust at the conference.
Published:
Last Updated:
If Warren Buffett is considered the greatest investor of the modern era, and if he has held the title of the world's richest man, then maybe he knows a thing or two.
Published:
Last Updated: